HELX icon

Franklin Genomic Advancements ETF

7 hedge funds and large institutions have $2.48M invested in Franklin Genomic Advancements ETF in 2024 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
2
Reduced
2
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
GT
1
Glenview Trust
Kentucky
$1.03M 32,625
GS
2
GTS Securities
New York
$874K 27,603 +13,899 +101%
LPL Financial
3
LPL Financial
California
$343K 10,823 +1,585 +17%
Commonwealth Equity Services
4
Commonwealth Equity Services
Massachusetts
$212K 6,677 -365 -5%
HI
5
Harbour Investments
Wisconsin
$5.96K 188
Osaic Holdings
6
Osaic Holdings
Arizona
$5.83K 184 -113 -38%
UBS Group
7
UBS Group
Switzerland
$1.33K 42 +42 New
Jane Street
8
Jane Street
New York
-13,886 Closed
Citadel Advisors
9
Citadel Advisors
Florida
-11,072 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
-6,934 Closed
Citigroup
11
Citigroup
New York
-15 Closed
CFGS
12
Concourse Financial Group Securities
Alabama